Compare AMKR & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMKR | FMS |
|---|---|---|
| Founded | 1968 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 109698 |
| Industry | Semiconductors | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.5B |
| IPO Year | 1997 | N/A |
| Metric | AMKR | FMS |
|---|---|---|
| Price | $71.03 | $22.51 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $56.00 | $30.00 |
| AVG Volume (30 Days) | ★ 3.4M | 451.3K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | 0.44% | ★ 2.52% |
| EPS Growth | ★ 4.90 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $4,052,650,000.00 | N/A |
| Revenue This Year | $13.24 | N/A |
| Revenue Next Year | $9.90 | $3.83 |
| P/E Ratio | $51.01 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.54 | $20.96 |
| 52 Week High | $79.23 | $30.46 |
| Indicator | AMKR | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 43.72 |
| Support Level | $40.96 | $22.50 |
| Resistance Level | N/A | $24.02 |
| Average True Range (ATR) | 3.95 | 0.37 |
| MACD | 1.23 | -0.06 |
| Stochastic Oscillator | 69.84 | 0.74 |
Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.